DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Fresolimumab is an investigational drug.
There have been 5 clinical trials for Fresolimumab. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2011.
The most common disease conditions in clinical trials are Breast Neoplasms, Sclerosis, and Scleroderma, Systemic. The leading clinical trial sponsors are Genzyme, a Sanofi Company, University of California, Los Angeles, and University of Nebraska.
There are eight US patents protecting this investigational drug and sixty-five international patents.
Recent Clinical Trials for Fresolimumab
|Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta||Genzyme, a Sanofi Company||Phase 1|
|Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta||Hospital for Special Surgery, New York||Phase 1|
|Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta||Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||Phase 1|
Top disease conditions for Fresolimumab
Top clinical trial sponsors for Fresolimumab
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Fresolimumab||Start Trial||Determination of TGF-.beta. pathway activity using unique combination of target genes||KONINKLIJKE PHILIPS N.V. (Eindhoven, NL)||Start Trial|
|Fresolimumab||Start Trial||Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein||CureVac AG (Tubingen, DE)||Start Trial|
|Fresolimumab||Start Trial||Cholestosome vesicles for incorporation of molecules into chylomicrons||THERASYN SENSORS, INC. (Eggertsville, NY)||Start Trial|
|Fresolimumab||Start Trial||Imaging composition and uses thereof||The University of Melbourne (Melbourne, AU)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|